Yacoub Habib
Directeur Général chez Ophidion, Inc.
Profil
Yacoub Habib is currently the Chief Executive Officer & Director at Ophidion, Inc. He previously worked as the Executive Director-New Business Development at Pfizer Inc. from 2007 to 2009, as the Executive Director-Global Business Development at Organon Pharmaceuticals USA, Inc., and as the Vice President-Business Development at Ikaria, Inc. from 2007 to 2009.
He also worked as the SVP-Business Development & Corporate Planning at Trevena, Inc. from 2015 to 2018.
Dr. Habib holds a doctorate from the University of Maryland and an MBA from The Leonard N Stern School of Business.
Postes actifs de Yacoub Habib
| Sociétés | Poste | Début |
|---|---|---|
Ophidion, Inc.
 Ophidion, Inc. BiotechnologyHealth Technology Ophidion, Inc. is an early-stage central nervous system biopharmaceutical company. The company was founded by Julie Miwa and is headquartered in Pasadena, CA. | Directeur Général | - |
Anciens postes connus de Yacoub Habib
| Sociétés | Poste | Fin |
|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 01/05/2018 |
| IKARIA, INC. | Corporate Officer/Principal | 01/01/2009 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2009 |
Organon Pharmaceuticals USA, Inc.
 Organon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Organon Pharmaceutical USA, Inc. markets and distributes pharmaceutical products. Its products include contraceptives and anesthetics, as well as treatments for mental health disorders. The company is headquartered in Roseland, NJ. | Corporate Officer/Principal | - |
Formation de Yacoub Habib
| University of Maryland | Doctorate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TREVENA, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Organon Pharmaceuticals USA, Inc.
Organon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Organon Pharmaceutical USA, Inc. markets and distributes pharmaceutical products. Its products include contraceptives and anesthetics, as well as treatments for mental health disorders. The company is headquartered in Roseland, NJ. | Health Technology |
Ophidion, Inc.
Ophidion, Inc. BiotechnologyHealth Technology Ophidion, Inc. is an early-stage central nervous system biopharmaceutical company. The company was founded by Julie Miwa and is headquartered in Pasadena, CA. | Health Technology |
